Dissertations at MEB

2023

• Bai G. Epidemiological studies on frailty and its associations with mortality, dementia, and polypharmacy. Stockholm: Karolinska Institutet; 2023/02/08. 
• Brand A. Prediction-driven decision rules, RCT design and survival analysis. Stockholm: Karolinska Institutet; 2023/04/28.
• Chen C. The general factor of psychopathology: precursors and consequences. Stockholm: Karolinska Institutet; 2023/09/01.
• Du Y. Prognosis of nasopharyngeal carcinoma: body mass index, plasma Epstein-Barr virus DNA and oral microbiome. Stockholm: Karolinska Institutet; 2023/06/20.
• Gotby V. Register-based studies of sex steroid hormones and psychiatric disorders. Stockholm: Karolinska Institutet; 2023/02/17.
• Hellgren R. Beyond mammography: an evaluation of complementary modalities in breast imaging. Stockholm: Karolinska Institutet; 2023/05/15.
• Liu S. Comorbidity between neurodevelopmental disorders and childhood-onset type 1 diabetes. Stockholm: Karolinska Institutet; 2023/09/25.
• Lu P. Integrative omics data analysis to discover novel signatures in complex diseases.Stockholm: Karolinska Institutet; 2023/03/31. 
• Mak, Ka Long Jonathan. Genetics and biomarkers of frailty: towards individualized management of the frailty syndrome. Stockholm: Karolinska Institutet; 2023/11/16.
• Mao, X. Epidemiological studies on breast cancer risk factors and screening. Stockholm: Karolinska Institutet; 2023/10/23. 
• Nguyen T-D. Genetic epidemiology of depression subgroups and suicide attempts. Stockholm: Karolinska Institutet; 2023/12-/15.
• Olsson H. Personalized prostate cancer management: AI-assisted prostate pathology and improved active surveillance. Stockholm: Karolinska Institutet; 2023/02/03. 
• Skourlis N. Development and application of competing risks and multi-state models in cancer epidemiology. Stockholm: Karolinska Institutet; 2023/03/17.
• Smew AI. Epidemiological aspects of type 1 diabetes: early life origins, childhood comorbidities, and adult outcomes. Stockholm: Karolinska Institutet; 2023/09/27.
• Szilcz, M. Potential overtreatment during life-limiting illness and end of life in older adults. Stockholm: Karolinska Institutet; 2023/11/10.
• Termorshuizen JD. Genetic and environmental factors influencing the risk and course of eating disorders. Stockholm: Karolinska Institutet; 2023/12/08.
• Weitz P. Artificial intelligence in histopathology image analysis for cancer precision medicine. Stockholm: Karolinska Institutet; 2023/10/27.
• Zeng E. Adjuvant hormone therapy in breast cancer patients: a special focus on treatment discontinuation. Stockholm: Karolinska Institutet; 2023/05/12.
• Zhang L. Developmental trajectories of attention-deficit/hyperactivity disorder into adulthood and aging: multimorbidity and polypharmacy. Stockholm: Karolinska Institutet; 2023/02/10.

2022

• Bergman D. Microscopic colitis: epidemiology, death and associated disorders. Stockholm: Karolinska Institutet; 2022/06/03.
• Forss A. Medical and surgical treatment of inflammatory bowel disease. Stockholm: Karolinska Institutet; 2022/02/11.
• Gonzalez Ginestet, P. Machine learning methods for precision medicine. Stockholm: Karolinska Institutet 2022/08/19.
• Hao S. Prostate cancer testing in Sweden: the interplay between cost and effectiveness. Stockholm: Karolinska Institutet; 2022/12/09.
• Kang X. The gut-brain axis in Parkinson’s disease: epidemiological studies on causes, underlying mechanisms and novel treatments. Stockholm: Karolinska Institutet; 2022/03/18.
• Lagerberg T. Behavioural outcomes of treatment with selective serotonin reuptake inhibitors. Stockholm: Karolinska Institutet; 2022/01/21.
• Leone M. Depression in youth and adults: etiology, outcomes, and comorbidities. Stockholm: Karolinska Institutet; 2022/02/25. 
• Nartey, YA. A clinical epidemiological study on end-stage liver disease in Ghana. Stockholm: Karolinska Institutet; 2022/06/22.
• Severi E. Epidemiology, prevention and control of hepatitis A virus infection in the European Union. Stockholm: Karolinska Institutet; 2022/11/07.
• Strandberg R. Breast cancer natural history models and risk prediction in mammography screening cohorts. Stockholm: Karolinska Institutet; 2022/04/22.
• Tate A. The development of psychiatric disorders and adverse behaviors: from context to prediction. Stockholm: Karolinska Institutet; 2022/02/18.
• Wang C. Register-based studies of infertility and the use of assisted reproductive techniques: possibilities and challenges. Stockholm: Karolinska Institutet; 2022/08/26. 
• Wang, Y. Artificial intelligence for breast cancer precision pathology. Stockholm: Karolinska Institutet; 2022/12/01.
• Zhang J. Epidemiological studies on gastroesophageal reflux disease and esophageal cancer. Stockholm: Karolinska Institutet; 2022/09/02.
• Zhang R. Convergent etiology among schizophrenia, eating disorders, and other medical conditions. Stockholm: Karolinska Institutet; 2022/01/14.

Previous years

2021

• Chen Y. An epidemiological study on nasopharyngeal carcinoma. Stockholm: Karolinska Institutet; 2021/11/16.
• Deng W. Improved statistical methodology for high-throughput omics data analysis. Stockholm: Karolinska Institutet; 2021/09/17.
• Eriksson M. Risk assessment and prevention of breast cancer. Stockholm: Karolinska Institutet; 2021/01/15.
• Li X. Biological ages: correlations, genetic determinants, and health outcomes. Stockholm: Karolinska Institutet; 2021/11/11.
• Lundholm C. Causes and consequences of stress and tobacco exposure in utero on birth size, asthma and academic achievement. Stockholm: Karolinska Institutet; 2021/03/26.
• Jangmo A. Attention-Deficit/Hyperactivity Disorder and educational outcomes: etiology, treatment effects, and occupational outcomes. Stockholm: Karolinska Institutet; 2021/09/03.
• Trevisan M. Drug safety and effectiveness in relation to kidney function: a pharmacoepidemiological approach. Stockholm: Karolinska Institutet; 2021/12/06.
• Veličko I. Chlamydia trachomatis infection in Sweden: time trends, risk factors, and prevalence. Stockholm: Karolinska Institutet; 2021/03/12.
• Yu J. Etiology and early detection of pancreatic cancer. Stockholm: Karolinska Institutet; 2021/11/30. 

2020

• Azam S. Determinants and influence of mammographic features on breast cancer risk. Stockholm: Karolinska Institutet; 2020/12/11.
• Ekheden I. Etiology and prognosis of gastroesophageal cancers. Stockholm: Karolinska Institutet; 2020/06/12.
• Huang T. Dietary Habits, Commensal Microbiome, and Nasopharyngeal Carcinoma. Stockholm: Karolinska Institutet; 2020/12/17.
• Lei J. Prevention and prognosis of cervical cancer: the interplay of human papillomavirus, vaccination and screening. Stockholm: Karolinska Institutet; 2020/03/20.
• Malki N. Epidemiological studies on socioeconomic inequalities and cardiovascular disease: prevention, progression and prognosis. Stockholm: Karolinska Institutet; 2020/03/13.
• Ning Z. Novel statistical methods for genome-wide association summary statistics. Stockholm: Karolinska Institutet; 2020/09/11.
• Shen Q. Stress during cancer diagnostic workup. Stockholm: Karolinska Institutet; 2020/04/17.
• Sieurin J. Personality, stress and risk of Parkinson's disease. Stockholm: Karolinska Institutet; 2020/05/29.
• Ström P. Artificial intelligence for streamlining prostate cancer diagnostics. Stockholm: Karolinska Institutet; 2020/05/15.
• Sun S. Attention-deficit/hyperactivity disorder and adverse health outcomes: from association to prevention. Stockholm: Karolinska Institutet; 2020/12/15.
• Ugalde Morales E. Molecular epidemiology studies on risk factors for breast cancer and disease aggressiveness. Stockholm: Karolinska Institutet; 2020/10/02.
• Wang Y. DNA methylation and aging: a longitudinal study of old Swedish twins. Stockholm: Karolinska Institutet; 2020/01/31.
• Wiklund C. Investigations of body mass, gastrointestinal, and dietary factors influencing the emergence and maintenance of eating disorders. Stockholm: Karolinska Institutet; 2020/11/13.

2019

• Beauté J. Epidemiology, prevention and control of Legionnaires’ disease in Europe. Stockholm: Karolinska Institutet; 2019-12-11.
• Bosire R. Maternal antibody transfer in HIV-1 infected women and impact on infant health: the role of antiretroviral prophylaxis and breastfeeding practices.  Stockholm: Karolinska Institutet; 2019/04/12.
• Dahlqwist E. Method developments for the attributable fraction in causal inference. Karolinska Institutet. 2019/05/25.
• Ericsson M. Socioeconomic influences on late-life health and mortality: exploring genetic and environmental interplay. Stockholm: Karolinska Institutet; 2019/10/04.
• Ghirardi L. The comorbidity between attention-deficit/hyperactivity disorder and other neurodevelopmental disorders: aetiology, treatment and outcomes. Stockholm: Karolinska Institutet; 2019/10/11.
• Isheden G. Statistical models of breast cancer tumour growth and spread. Stockholm: Karolinska Institutet; 2019/12/10.
• Karlsson A. Microsimulation modelling of prostate cancer screening in Sweden. Stockholm: Karolinska Institutet; 2019/05/13.
• Longinetti E. Amyotrophic lateral sclerosis and multiple sclerosis associated neuroinflammation: nationwide epidemiological studies on etiology, comorbidities, and treatment. Stockholm: Karolinska Institutet; 2019/12/18.
• Plym A. Breast and prostate cancer: the impact of diagnosis and treatment on sick leave and work. Stockholm: Karolinska Institutet; 2019/01/18.
• Palsdottir T. Risk prediction in prostate cancer diagnostics: current challenges and improvements. Stockholm: Karolinska Institutet; 2019/09/27.
• Radkiewicz C. Sex differences in cancer risk and survival. Stockholm: Karolinska Institutet; 2019/12/06.

2018

• Abrahamsson L. Statistical models of breast cancer tumour progression for mammography screening data. Stockholm: Karolinska Institutet; 2018/10/11.
• Bokenberger K. The role of sleep and shift work in dementia and cognitive aging: an epidemiological approach. Stockholm: Karolinska Institutet; 2018/05/25.
• Bower H. Flexible parametric models for cancer patient survival: loss in expectation of life and further developments. Stockholm: Karolinska Institutet; 2018/03/23.
• Brikell I. ADHD, epilepsy, and related childhood psychopathology: understanding shared genetic risk, developmental trajectories, and pharmacological treatment safety. Stockholm: Karolinska Institutet; 2018/04/20.
• Chen X. Genetic epidemiology of cardiometabolic biomarkers: Twin studies in the Genomic era. Stockholm: Karolinska Institutet; 2018/06/15.
• Holm J. Aggressive breast cancer: Epidemiological studies addressing disease heterogeneity. Stockholm: Karolinska Institutet; 2018/02/23.
• Lamb F. Vaccine safety, vaccine effectiveness and other determinants for successful immunisation programmes. [Licentiate thesis] Stockholm: Karolinska Institutet; 2018/06/19.
• Liu B. Parkinson’s disease etiology: beyond the brain and late adulthood. Stockholm: Karolinska Institutet; 2018/09/18.
• Lundberg F. Impact of infertility and assisted reproductive technology on cancer risk. Stockholm: Karolinska Institutet; 2018/06/01.
• Rejno G. Asthma, anxiety and depression in pregnancy : the impact on pregnancy, delivery and perinatal outcomes. Stockholm: Karolinska Institutet; 2018/05/18.
• Strand F. Determinants of interval cancer and tumor size among breast cancer screening participants. Stockholm: Karolinska Institutet; 2018/06/08.
• Weibull CE. Survivorship in Hodgkin lymphoma: childbearing and treatment-related disease. Stockholm: Karolinska Institutet; 2018/11/09.
• Yang H. Panorama of diseases associated with breast cancer. Stockholm: Karolinska Institutet; 2018-12-07.
• Xu H. Diet, lifestyle and chronic kidney disease. Stockholm: Karolinska Institutet; 2018/10/15.
• Yao S. Genetic and environmental influences on eating disorders and associated adversities and comorbidities. Stockholm: Karolinska Institutet; 2018/03/09.
• Zhan Y. A short story of the long telomere: evidence in aging epidemiology. Stockholm: Karolinska Institutet; 2018/04/27.

2017

• Cesta C. Stress, depression, and other psychiatric disorders : an epidemiological approach to studying the causes and consequences for in vitro fertilization outcome and polycystic ovary syndrome. Stockholm: Karolinska Institutet; 2017/05/12.
• Chen R. Parental cancer and children’s well-being: understanding the potential role of psychological stress. Stockholm: Karolinska Institutet; 2017/04/28.
• Delcoigne B. Efficient design and analysis of extended case-control studies. Stockholm: Karolinska Institutet; 2017/06/01.
• Halmin M. Transfusion in critically ill patients: short- and long-term outcomes. Stockholm: Karolinska Institutet; 2017/03/17.
• Karlsson IK. Dementia and its comorbidities: genetic and epigenetic influences. Stockholm: Karolinska Institutet; 2017/09/22.
• Liu X. Generalized survival models as a tool for medical research. Stockholm: Karolinska Institutet; 2017/11/23.
• Lu D. The role of psychological stress in cervical and prostate carcinogenesis. Stockholm: Karolinska Institutet; 2017/06/16.
• Mariosa D. Metabolic disorders in the etiology of amyotrophic lateral sclerosis - an epidemiological approach. Stockholm: Karolinska Institutet; 2017/05/04.
• Sjörs C. Näringsintag och utsläpp av växthusgaser från svenska matvanor ur ett epidemiologiskt perspektiv. [Licentiate thesis]. Stockholm: Karolinska Institutet; 2017/11/15.
• Song J. Bipolar disorder and lithium treatment: etiologies and consequences. Stockholm: Karolinska Institutet; 2017/02/24.
• Wang J. Effectiveness and equity of cervical cancer prevention: real-life evidence from organised programmes in Sweden. Stockholm: Karolinska Institutet; 2017/12/18.
• Yang F. Can Parkinson’s disease be prevented? : epidemiological evidence on lifestyle factors. Stockholm: Karolinska Institutet; 2017/04/20.
• Zetterqvist J. Statistical methods for twin and sibling designs. Stockholm: Karolinska Institutet; 2017/05/11.

2016

• Cederlöf M. Risks, correlates, and consequences of the extended psychosis phenotype. Stockholm: Karolinska Institutet; 2016/03/11.
• Chen, Q. What can genetically informative designs add to the understanding of ADHD? Stockholm: Karolinska Institutet; 2016/03/18.
• Gong T. Epidemiological studies of asthma and neurodevelopmental disorders in children. Stockholm: Karolinska Institutet; 2016/04/22.
• Herweijer E. Register-based evaluation of HPV vaccination programs. Stockholm: Karolinska Institutet; 2016/06/13.
• Johansson ALV. Pregnancy and breast cancer: risk patterns, tumour characteristics and prognosis. Stockholm: Karolinska Institutet; 2016/04/08.
• Liu Z. Etiology and early detection of nasopharyngeal carcinoma: an epidemiological approach. Stockholm: Karolinska Institutet; 2016/08/31.
• Peters TL. Risk factors and amyotrophic lateral sclerosis: an epidemiologic approach. Stockholm: Karolinska Institutet; 2016/06/20.
• Trinh T. Determinants of breast cancer risk; focusing on mammographic density. Stockholm: Karolinska Institutet; 2016/01/15.
• Ullemar V. Transmitted and acquired determinants for childhood asthma - from genes to teens. Stockholm: Karolinska Institutet; 2016-10-21.

2015

• Aly, M.  Prostate Cancer Diagnostics - complications and ways to reduce unnecessary biopsies. Stockholm: Danderyds Sjukhus och Karolinska Institutet; 2015/01/30.
• Bonn, S. Physical activity, body mass index and prostate cancer: studies of risk, progression and mortality. Stockholm: Karolinska Institutet; 2015/03/27.
• Colzani, E. Health outcomes of women with breast cancer. Stockholm: Karolinska Institutet; 2015/01/15.
• Elfström KM. Optimizing cervical cancer prevention through screening and HPV vaccination. Stockholm: Karolinska Institutet; 2015/06/15.
• Ganna, A. Risk prediction models for cardiovascular disease and overall mortality. Stockholm: Karolinska Institutet; 2015/01/16.
• Huang J. Epidemiology and etiology of pancreatic cancer. Stockholm: Karolinska Institutet; 2015/12/10.
• Johansson V. Cerebrospinal fluid biomarkers in twins with schizophrenia and bipolar disorder. Stockholm: Karolinska Institutet; 2015/09/18.
• Lee, Myeongjee. Effects of kinship and timing in familial cancer. Stockholm: Karolinska Institutet; 2015/05/08.
• Nordström, T. Predicting Prostate Cancer - on the use of biomarkers in prostate cancer diagnostics. Stockholm: Danderyds Sjukhus och Karolinska Institutet; 2015/02/06.
• Sariaslan A. Exploring the causal nature of neighborhood influences on violent criminality, substance misuse and psychiatric morbidity. Stockholm: Karolinska Institutet; 2015/03/20.
• Song, H. Changes of stomach microenvironment and gastric cancer development. Stockholm: Karolinska Institutet; 2015/09/03.
• Szulkin, R. Genetic determinants for susceptibility, progression and prognosis of prostate cancer. Stockholm: Karolinska Institutet; 2015/11/13
• Viktorin, A. Mood disorders and consequences of pharmacological treatment. Stockholm: Karolinska Institutet; 2015/12/11.
• Örtqvist AK. Early life origins of asthma - genetic and environmental factors in twin and kin. Stockholm: Department of Medical Epidemiology and Biostatistics, Karolinska Institutet; 2015/04/17.

2014

• Christensen S. Diet in epidemiology: assessment, validity and association with upper respiratory tract infection. Stockholm: Karolinska Institutet; 2014/03/07.
• Feldman AL. If I only had a brain: Epidemiological Studies of Parkinson's disease. Stockholm: Karolinska Institutet; 2014/01/10.
• Ljung T. Parental characteristics and offspring internalizing behaviors: understanding the associations using quantitative genetics. Stockholm: Karolinska Institutet; 2014/01/31.
• Orem J. Etiological risk factors and clinical characteristics of childhood non-hodgkin lymphoma in Uganda. Stockholm: Karolinska Institutet and Makerere University; 2014/08/29.
• Kuja-Halkola R. Twin and family studies on the development of cognitive and externalizing problems. Stockholm: Karolinska Institutet; 2014/02/28.
• Kyaga S. Creativity and psychopathology. Stockholm: Karolinska Institutet; 2014/03/21.
• Sellgren C. On neuroinflammation in psychotic disorders. Stockholm: Karolinska Institutet; 2014/10/03.
• Song, C. Lipid-related Genes and Their Associations with Coronary Heart Disease. Stockholm: Karolinska Institutet; 2014/05/16.
• Suo, C. Statistical methods for the detection, analyses and integration of biomarkers in the human genome and transcriptome. Stockholm: Karolinska Institutet; 2014/09/26.
• Törner A. Statistical methods for long-term follow-up of infectious disease. Stockholm: Karolinska Institutet; 2014/03/14.

2013

• Andersson T. M-L. Quantifying cancer patient survival: extensions and applications of cure models and life expectancy estimation. Stockholm: Karolinska Institutet; 2013/11/14.
• Chang Z. The Origins and Consequences of Attention Deficit Hyperactivity Disorder. Stockholm: Karolinska Institutet; 2013/11/08.
• Eloranta S. Development and application of statistical methods for population-based cancer patient survival. Stockholm: Karolinska Institutet; 2013/11/29.
• Frans E. High paternal age and risk of psychiatric disorders in offspring. Stockholm: Karolinska Institutet; 2013/10/31.
• Azerkan F. Cervical cancer : incidence, screening and prognosis among immigrant women in Sweden. Stockholm: Karolinska Institutet; 2013/09/03
• Gustafsson S. Adiponectin: Genetic determinants and relations with subclinical cardiovascular disease. Stockholm: Karolinska Institutet; 2013/01/24.
• He G. Genetic predisposition and dietary factors in relation to adiponectin and insulin resistance. Stockholm: Karolinska Institutet; 2013/09/17.
• Karlsson R. Molecular epidemiology of complex heritable disease: applications in genomics and metabolomics. Stockholm: Karolinska Institutet; 2013/01/25.
• Merk H. Development of methods for population-based surveillance of influenza. Stockholm: Karolinska Institutet; 2013/10/10.
• Möller E. Epidemiological studies of diet quality, body size and prostate cancer risk. Stockholm: Karolinska Institutet; 2013-11-15.
• Neiman M. Methods for deep examination of DNA. Stockholm: Karolinska Institutet; 2013/05/30.
• Nasrollahzadeh Nesheli D. Risk factors for esophageal squamous cell carcinoma. Stockholm: Karolinska Institutet; 2013.
• Rahman I. Molecular and psychosocial risk factors for cardiovascular disease. Stockholm: Karolinska Institutet; 2013/04/19.
• Sundstrom K. Human papillomavirus test and vaccination - impact on cervical cancer screening and prevention. Stockholm: Karolinska Institutet; 2013/01/19.
• Tettamanti G. Studies on risk factors for urinary incontinence in Swedish female twins. Stockholm: Karolinska Institutet; 2013/10/11.
• Tiikkaja S. Social mobility in relation to cardiovascular and psychiatric health. Stockholm: Karolinska Institutet; 2013/03/08.

2012

• Berglund A. Socioeconomic factors and the influence of comorbidity in the management and survival in lung and prostate cancer. Stockholm: Karolinska Institutet; 2012/02/17.
• Fransson M. Mathematical model development to investigate the pharmacokinetic variability of two anticancer drugs. Stockholm: Karolinska Institutet; 2012/03/23.
• Darabi H. Genetic association and risk prediction of breast cancer from an epidemiological and biostatistical perspective. Stockholm: Karolinska Institutet; 2012/03/09.
• Eriksson, L. Mammographic density and breast cancer phenotypes. Stockholm: Karolinska Institutet; 2012/11/08.
• Frisell T. Violent crime: addressing causation with family-based methods. Stockholm: Karolinska Institutet; 2012/06/08.
• Högberg L. Prenatal influences on health outcomes over the lifespan. Effects of smoking, socio-economic status and foetal growth. Stockholm: Karolinska Institutet; 2012/10/05.
• Kasiman K. The genetic and molecular markers of ischemic stroke: risk, prognosis and treatment. Stockholm: Karolinska Institutet; 2012/10/19.
• Levál A. Assessing infection risk and evaluating prevention strategies in the era of HPV-vaccines. Stockholm: Karolinska Institutet; 2012/11/09.
• Sandberg MEC. Contralateral breast cancer - risk and prognosis. Stockholm: Karolinska Institutet; 2012/09/06.
• Teo SM. Statistical methods for the detection and analyses of structural variants in the human genome. Stockholm: Karolinska Institutet; 2012/09/07.
• Walum H. Genetic and hormonal influences on affiliative behavior in humans. Stockholm: Karolinska Institutet; 2012/06/01

2011

• Fondell E. Web-based studies of lifestyle factors and immune function. Stockholm: Karolinska Institutet; 2011/02/04.
• Halthur C. Cancer and Calcium - Epidemiological studies of Cancer Incidence and Survival. Stockholm: Karolinska Institutet; 2011/04/08.
• Hong M-G. Genomics and bioinformatics strategies in the study of aging and Alzheimer disease. Stockholm: Karolinska Institutet; 2011/03/11.
• Li J. Genetic determinants of breast cancer risk. Stockholm: Karolinska Institutet; 2011/02/18.
• Narasimhalu K. Health outcomes associated with cognitive impairment. Stockholm: Karolinska Institutet; 2011/10/07.
• Talbäck M. Cancer patient survival in Sweden - theory and application. Stockholm: Karolinska Institutet; 2011/12/09.
• Zheng Z. Molecular Epidemiologic Studies on Helicobacter pylori Infection and Stomach Cancer Risk. Stockholm: Karolinska Institutet; 2011/08/23.
• Öberg S. Health consequences of adverse fetal growth - studies in twins. Stockholm: Karolinska Institutet; 2011/06/17.

2010

• Camitz M. Computer aided infectious disease epidemiology - bridging to public health. Stockholm: Karolinska Institutet; 2010/11/12.
• Eriksson, Ulrika K. Inflammation-associated risk factors for Alzheimers disease and dementia. Karolinska Institutet. 2010/03/12
• Fang, Fang. Epidemiologic studies of amytrophic lateral sclerosis. Karolinska Institutet. 2010/01/29
• Melin A-S. The risk of malignancy in women with endometriosis. Stockholm: Karolinska Institutet; 2010/03/26.
• Nordenvall C. Aspects of the etiology and survival of lower gastrointestinal cancers. Stockholm: Karolinska Institutet; 2010/03/19.
• Odida M. Cervical carcinoma in Kampala, Uganda and the relationship with human immunodeficiency virus and human Papillomavirus infections. Kampala and Stockholm: Makerere University and Karolinska Institutet; 2010/10/25.

2009

• Ateenyi Agaba C. Human papillomaviruses and their association with squamous cell carcinoma of the conjunctiva. Kampala and Stockholm: Makerere University and Karolinska Institutet; 2009/10/28.
• Banura C. Human papillomavirus infections among sexually active young women in Uganda : Implications for a vaccination strategy. Kampala and Stockholm: Makerere University and Karolinska Institutet; 2009/10/26.
• Bexelius C. E-epidemiology : Adapting epidemiological methods for the 21st century. Stockholm: Karolinska Institutet; 2009/09/18.
• Fernberg P. Hematolymphoproliferative malignancies - the impact of lifestyle, organ transplantation and genetic susceptibility. Stockholm: Karolinska Institutet; 2009/02/20.
• Forsman M. Psychopathic personality in adolescence: Genetic and environmental influences. Stockholm: Karolinska Institutet; 2009/09/25.
• Mutyaba TS. Early cervical lesions detected by visual inspection : Viral factors, management and follow-up. Kampala and Stockholm: Makerere University and Karolinska Institutet; 2009/10/30.
• Narusyte J. Adolescent adjustment problems: the role of heritability and family environment. Stockholm: Karolinska Institutet; 2009/09/11.
• Odenbro Å. Skin cancer in relation to tobacco use and organ transplantation. Stockholm: Karolinska Institutet; 2009/01/23.
• Orgéas CC. Endogenous and exogenous hormonal factors in female cancers: Studies of risk and prognosis. Stockholm: Karolinska Institutet; 2009/02/27.
• Persson C. Roles of Helicobacter pylori infection, host genetic variation, and other environmental exposures in gastric carcinogenesis. Stockholm: Karolinska Institutet; 2009/11/27
• Sjölander A. Causal inference in epidemiological research. Stockholm: Karolinska Institutet; 2009/02/06.
• Svensson A. Family studies of schizophrenia and pregnancy outcomes. Stockholm: Karolinska Institutet; 2009/01/16.

2008

• Buchmayer S. Infections and infectious related morbidity during pregnancy: Short and long-term effects. Stockholm, Karolinska Institutet; 2008/11/28.
• Johansson S. Very preterm birth - etiological aspects and short and long term outcomes. Stockholm: Karolinska Institutet; 2008/03/28.
• Jonasdottir G. Statistical methodology for testing genetic association in family-based studies. Stockholm: Karolinska Institutet; 2008/04/25.
• Miao Jonasson J. Epidemiological studies on complications in type 1 diabetes. Stockholm: Karolinska Institutet; 2008/03/14.
• Leu M. Truncation and missing family links in population-based registers. Stockholm: Karolinska Institutet; 2008/03/07.
• Lindström LS. Population-based family studies: Genetic contribution to cancer development and survival? Stockholm: Karolinska Institutet; 2008/10/09.
• Luo J. Epidemiological studies of the etiology of pancreatic cancer. Stockholm: Karolinska Institutet; 2008/01/11.
• Tan CS. Statistical methods for biomarker discovery in proteomics. Stockholm: Karolinska Institutet; 2008/08/15.
• Ternhag A. Short and long term effects of bacterial gastrointestinal infection. Stockholm: Karolinska Institutet; 2008/05/09.
• Yip BH. Statistical Genetics Analysis of family data. Stockholm: Karolinska Institutet; 2008/08/22.

2007

• Bahmanyar S. Etiological aspects of gastroesophageal cancers. An epidemiological approach. Stockholm: Karolinska Institutet; 2007/06/04.
• Bergvall N. Fetal programming and subsequent risks in adulthood : Are the associations confounded by genetic and/or environmental factors? Stockholm: Karolinska Institutet; 2007/09/21.
• Edgren G. Blood donors' long-term health: implications for transfusion safety. Stockholm: Karolinska Institutet; 2007/09/21.
• Einarsdóttir K. Genetic determinants of postmenopausal breast and endometrial cancer. Stockholm: Karolinska Institutet; 2007/02/16.
• Gunnell AS. Risk factors for cervical cancer development. Stockholm: Karolinska Institutet; 2007/12/14.
• Hartman M. Risk and prognosis of breast cancer among women at high risk of the disease. Stockholm: Karolinska Institutet; 2007/10/12.
• Kato K. Genetic Epidemiological Studies of the Functional Somatic Syndromes: Chronic Widespread Pain and Chronic Fatigue. Stockholm: Karolinska Institutet; 2007/02/23.
• Zendehdel K. Risk indicators for esophageal cancer: Some medical conditions and tobacco-related factors. Stockholm: Karolinska Institutet; 2007/06/04.

2006

• Berglund T. Recent trends in the epidemiology of gonorrhoea in Sweden. Stockholm: Swedish Institute for Infectious Disease Control and Karolinska Institutet; 2006/06/08.
• Dannetun E. Reasons for non-vaccination. Stockholm: Karolinska Institutet; 2006/06/15.
• De Jong Skierus, B. Human salmonellosis - impact of travel and trade from a Swedish perspective. Stockholm, Karolinska Institutet, 2006/09/29.
• Ekman A. The use of the world wide web in epidemiological research. Stockholm: Karolinska Institutet; 2006/10/27.
• George L. Spontaneous abortion: risk factors and measurement of exposures. Stockholm: Karolinska Institutet; 2006/10/13.
• Hedelin M. Dietary and genetic factors in the etiology of prostate cancer. Stockholm: Karolinska Institutet; 2006/06/09.
• Högberg L. Penicillin-resistant pneumococci in Sweden: Epidemiology and public health response. Stockholm, Karolinska Institutet, 2006/01/20.
• Ihre Lundgren C. Incidence and prognosis of differentiated thyroid cancer in Sweden. Stockholm: Karolinska Institutet; 2006/01/27.
• Johansson J. Barrett's oesophagus and metaplasia at the oesophagogastric junction. An epidemiological approach. Stockholm: Karolinska Institutet; 2006/11/24.
• Lobacheva T. Pulmonary tuberculosis in pre-trial detentions in St.Petersburg, Russia [Licentiate thesis]. Stockholm: Karolinska Institutet; 2006.
• Nilsson E. Genetic epidemiological studies of adverse pregnancy outcomes and the role of schizophrenia. Stockholm: Karolinska Institutet; 2006/03/17.
• Prochazka M. The risk of second primary lung carcinoma in breast cancer patients. Stockholm: Karolinska Institutet; 2006/02/24.
• Rosenberg L. Hormone-related factors and breast cancer - studies of risk and prognosis. Stockholm: Karolinska Institutet; 2006/09/08.
• Svedberg P. Factors of importance for self-rated health. Stockholm: Karolinska Institutet; 2006/03/31.
• Trolle Lagerros Y. Physical activity from the epidemiological perspective - measurement issues and health effects. Stockholm: Karolinska Institutet; 2006/06/16.
• Tuvblad C. Genetic and environmental influences on antisocial behavior from childhood to emerging adulthood. Stockholm: Karolinska Institutet; 2006/11/23.

2005

• Ejerblad E. Some lifestyle-related factors and risk of chronic renal failure. Stockholm: Karolinska Institutet; 2005/03/05.
• Ekström Smedby K. Ultraviolet light, autoimmune disorders and the etiology of malignant lymphomas. Stockholm: Karolinska Institutet; 2005/06/03.
• Jansson C. Occupational and socio-economic factors in the etiology of cancer of the esophagus and gastric cardia. Stockholm: Karolinska Institutet; 2005/10/07.
• Kivi M. Aspects of helicobacter pylori transmission. Stockholm: Karolinska Institutet; 2005/10/22.
• Larsson H. Genetic and environmental factors in the development of externalising symptoms from childhood to adolescence. Stockholm: Karolinska Institutet; 2005/03/12.

2004

• Fall K. Medical interventions and gastric cancer risk - an observational approach. Stockholm: Karolinska Institutet; 2004/06/04.
• Gusnanto A. Regression on high-dimensional predictor space with application in chemometrics and microarray data. Stockholm: Karolinska Institutet; 2004/12/17.
• Held M. Epidemiological studies of helicobacter pylori and its relation to cancer and precancerous lesions in the upper gastrointestinal tract. Stockholm: Karolinska Institutet; 2004/06/11.
• Jansson M. Genetic studies of depressive symptoms. Stockholm: Karolinska Institutet; 2004/02/27.
• Larfors G. Pregnancy related risk factors for breast cancer. Stockholm: Karolinska Institutet; 2004/01/09.
• Nilsson M. Etiology of gastroesophageal reflux. Stockholm: Karolinska Institutet; 2004/05/07.
• Norman, A. Physical activity in men and relation to prostate cancer [licentiate]. Stockholm, Karolinska Institutet: 2004/05/28.
• Richiardi L. New evidence on germ-cell testicular cancer aetiology. Stockholm: Karolinska Institutet; 2004/01/30.
• Wedrén S. Genetic susceptibility to breast and endometrial cancer. Stockholm: Karolinska Institutet; 2004/10/01.
• Wirdefeldt K. Studies of genetic and environmental influence on Parkinson's disease. Stockholm: Karolinska Institutet; 2004/02/20.

2003

• Eaker S. Optimization of compliance in epidemiologic research and disease prevention. Stockholm: Karolinska Institutet; 2003/04/04.
• Fored M. Risk factors for the development of chronic renal failure. Epidemiological studies on the role of analgesic use, occupational exposures and socioeconomic background. Stockholm: Karolinska Institutet; 2003/02/07.
• Iliadou A. Genetic epidemiological approaches to the study of risk factors for cardiovascular diseases. Stockholm: Karolinska Institutet; 2003/05/28.
• Ye W. Aspects of gastroesophageal reflux and risk for esophageal cancer. An epidemiological approach. Stockholm: Karolinska Institutet; 2003/11/14.

2002

• Hübinette A. Exposures in utero and chronic disease. An alternative methodological approach. Stockholm: Karolinska Institutet; 2002/09/20.
• Kaijser M. Does cancer originate in utero? Epidemiological evaluation of a hypothesis. Stockholm, Sweden: Karolinska Institutet; 2002/03/15.
• Lagerlund M. Factors affecting attendance at population-based mammography screening. Stockholm: Karolinska Institutet; 2002/02/01.
• Stephansson O. Epidemiological studies of stillbirth and early neonatal death. Stockholm, Sweden: Karolinska Institutet; 2002/03/08.

2001

• Askling J. Epidemiological studies of host susceptibility in malignant lymphomas and colorectal cancer. Stockholm, Sweden: Karolinska Institutet; 2001/04/06.
• Bergfeldt K. Malignancies associated with gynecological cancer - epidemiological and etiological aspects. Stockholm, Sweden: Karolinska Institutet; 2001/10/26.
• Bergström A. Renal cell cancer: the role of physical activity and body size. Stockholm, Sweden: Karolinska Institutet; 2001/02/23.
• Salonen Ros H. Preeclampsia and other circulatory diseases during pregnancy - etiological aspects and impact on female offspring. Stockholm, Sweden: Karolinska Institutet; 2001/03/22.
• Terry P. Dietary prevention of gastrointestinal cancer: epidemiologic studies of fruit, vegetables and cereals. Stockholm, Sweden: Karolinska Institutet; 2001/01/12.

2000

• Ekström AM. Factors related to the occurrence of gastric adenocarcinoma subtypes. Stockholm, Sweden: Karolinska Institutet; 2000/04/28.
• Moradi T. The role of physical activity in the prevention of breast and endometrial cancer. Stockholm, Sweden: Karolinska Institutet; 2000/10/06
• Otterblad Olausson P. Teenage childbearing: Pregnancy outcomes and long-term consequences for the mothers. Stockholm, Sweden: Karolinska Institutet; 2000/01/21.
• Ylitalo N. Human papillomavirus and cervical carcinoma in situ: Implications for future screening. Stockholm, Sweden: Karolinska Institutet; 2000/09/01.

1999

• Akre O. Etiological insights into the testicular cancer epidemic. Stockholm: Karolinska Institutet; 1999/12/10.
• Enroth H. Helicobacter pylori. Bacterial diversity and human disease. Stockholm: Karolinska Institutet; 1999/12/09.
• Lagergren J. Cancer of the esophagus and gastric cardia. Etiological aspects. Stockholm: Karolinska Institutet; 1999/03/26.
• Weiderpass E. Some hormonal factors in the etiology of endometrial cancer. Stockholm: Karolinska Institutet; 1999/06/07.

1998

• Blomqvist P. On the use of administrative databases in health care analyses. Stockholm: KI; 1998/03/12.
• Magnusson C. Breast cancer epidemiology. Influence of hormone-related factors. Stockholm: KI; 1998/04/17.

1997

• Adami J. Non-Hodgkin's lymphoma: a search for causes. Stockholm: KI; 1997/12/07.
• Kornfeld D. Inflammatory bowel disease - risk factors for adverse outcomes, and preventive measures. Stockholm: Karolinska Institutet; 1997/11/05.